Home › Thyroid Diseases › Texas › Houston
Thyroid Diseases clinical trials in Houston, TX
5 studies for Thyroid Diseases are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
RecruitingPhase 1
- MD Anderson, Houston
Study of BHV-1300 in Graves' Disease
RecruitingPhase 1
- Site-106, Houston
- Site-101, Houston
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
RecruitingPhase 1/2
- MD Anderson Cancer Center, Houston
A Study to Assess the Safety and Efficacy of Oral Armour Thyroid Compared to Synthetic T4 for the Treatment of Primary Hypothyroidism in Adult Participants
RecruitingPhase 2/3
- Juno Research /ID# 259238, Houston
- Biopharma Informatic - Houston - Business Center Drive /ID# 256149, Houston
- PlanIt Research, PLLC /ID# 259221, Houston
- and 1 more
Comprehensive Data Collection and Follow-Up for Patients With Thyroid, Parathyroid and Adrenal Disease
RecruitingObservational study
- University of Texas MD Anderson Cancer Center, Houston
About Thyroid Diseases
The thyroid is a gland in the neck. The thyroid gland creates hormones that affect metabolism. Learn about thyroid diseases, such as hypothyroidism.
More about Thyroid Diseases on MedlinePlus
Thyroid Diseases trials in other cities
- New York City, NY4 studies
- Memphis, TN3 studies
- Boston, MA3 studies
- Dallas, TX3 studies
- Miami, FL3 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)123 studies
- Metastatic Cancer104 studies
- Colorectal Cancer101 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia86 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer62 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.